These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 94261)

  • 1. [Retention time of colloid-osmotic infusions].
    Halmágyi M
    Beitr Infusionther Klin Ernahr; 1979; 2():51-68. PubMed ID: 94261
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects and adverse effects of colloid-containing solutions].
    Bergmann H
    Beitr Infusionther Klin Ernahr; 1979; 2():43-50. PubMed ID: 94260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Storing of plasma expanders in the reticuloendothelial system].
    Sonntag W; Paulini K
    Verh Dtsch Ges Pathol; 1978; 62():346. PubMed ID: 85388
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacokinetic considerations in the use of plasma expanders.
    Klotz U; Kroemer H
    Clin Pharmacokinet; 1987 Feb; 12(2):123-35. PubMed ID: 2435442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antishock blood substitute based on hydroxyethyl starch].
    Polushina TV; Prostakova TM; Bogino NA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Surg Gynecol Obstet; 1970 Nov; 131(5):965-72. PubMed ID: 5471548
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of HES, dextran and gelatin on kidney function].
    Vogt N; Brinkmann A; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):268-70. PubMed ID: 9617430
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies on the velocity of the elimination of plasma substitutes from the blood stream in rabbits.
    Nitschmann H; Stoll HR
    Bibl Haematol; 1969; 33():152-8. PubMed ID: 5383988
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic plasma volume expanders--their pharmacology, safety and clinical efficacy.
    Mishler JM
    Clin Haematol; 1984 Feb; 13(1):75-92. PubMed ID: 6202449
    [No Abstract]   [Full Text] [Related]  

  • 10. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
    Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
    Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of kidney function on the elimination and action of colloidal plasma substitutes].
    Köhler H
    Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
    Ring J; Seifert J; Struif E; Messmer K; Brendel W
    Chir Forum Exp Klin Forsch; 1977 Apr; ():31-5. PubMed ID: 87295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyethyl starch.
    Thompson WL
    Prog Clin Biol Res; 1978; 19():283-92. PubMed ID: 78499
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes.
    Zekorn D
    Bibl Haematol; 1969; 33():131-40. PubMed ID: 5383986
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthetic plasma substitutes].
    Giacomello M; Casiglia E; Gava R; Sforza G
    G Clin Med; 1989 Oct; 70(10):615-8. PubMed ID: 2480925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological findings in infusions of colloidal solutions].
    Richter W; Hedin H; Ring J
    Med Welt; 1977 Oct; 28(42):1717-9. PubMed ID: 73122
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of plasma substitutes of different molecular weight in acute haemorrhagic shock in dogs (author's transl)].
    Klose R; Hartung HJ; Ruffmann R; Lutz H
    Prakt Anaesth; 1979 Aug; 14(4):337-44. PubMed ID: 91161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 6% hydroxyethyl starch 130/0.42 and 4% gelatin on renal function in a pediatric animal model.
    Witt L; Glage S; Schulz K; Lichtinghagen R; Simann A; Pape L; Sümpelmann R
    Paediatr Anaesth; 2014 Sep; 24(9):974-9. PubMed ID: 24916275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.